Literature DB >> 9374010

Mandated AA attendance for recidivist drinking drivers: policy issues.

R Speiglman1.   

Abstract

Mandates for recidivist drinking drivers to attend AA meetings raise concerns about whether AA referral practices could have an adverse impact on both alcohol problems and traffic safety, whether routine and unregulated referrals to AA may prove detrimental to AA as an organization, and over ethical issues and possible loss of civil liberties. Similar issues arise in criminal justice and other agencies' handling of a variety of situations beyond the DUI arena. As a result institutions mandating involvement in mutual aid programs such as AA, and a variety of treatment settings, should adopt cautious referral practices, support rigorous research and create and evaluate targeted programs and integrated services.

Entities:  

Mesh:

Year:  1997        PMID: 9374010

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  4 in total

1.  Do adolescents affiliate with 12-step groups? A multivariate process model of effects.

Authors:  John F Kelly; Mark G Myers; Sandra A Brown
Journal:  J Stud Alcohol       Date:  2002-05

2.  Incorporating a public health approach in drug law: lessons from local expansion of treatment capacity and access under California's Proposition 36.

Authors:  Dorie Klein; Robin E Miller; Amanda Noble; Richard Speiglman
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

3.  Comparison of 12-step groups to mutual help alternatives for AUD in a large, national study: Differences in membership characteristics and group participation, cohesion, and satisfaction.

Authors:  Sarah E Zemore; Lee Ann Kaskutas; Amy Mericle; Jordana Hemberg
Journal:  J Subst Abuse Treat       Date:  2016-10-06

4.  Twenty-one-year trends and correlates of pressure to change drinking.

Authors:  Douglas L Polcin; Rachael Korcha; Thomas K Greenfield; Jason Bond; William Kerr
Journal:  Alcohol Clin Exp Res       Date:  2011-09-13       Impact factor: 3.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.